KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 5 analysts with an average price target of $26.85. This is a potential upside of $16.65 (163.24%) from yesterday's end of day stock price of $10.2.

Keros Therapeutics 's activity chart (see below) currently has 23 price targets and 39 ratings on display. The stock rating distribution of KROS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.82% with an average time for these price targets to be met of 24.86 days.

Highest price target for KROS is $47, Lowest price target is $15, average price target is $26.85.

Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 17-Jan-2025. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 24 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$4.14 (38.12%)

$105

26 days ago
(17-Jan-2025)

5/12 (41.67%)

$4.58 (43.95%)

43

Buy

$15

$4.14 (38.12%)

$63

26 days ago
(17-Jan-2025)

0/8 (0%)

$4.58 (43.95%)

Buy

$43

$32.14 (295.95%)

$100

1 months 20 days ago
(23-Dec-2024)

0/5 (0%)

$25.93 (151.90%)

Buy

$47

$36.14 (332.78%)

$100

1 months 30 days ago
(13-Dec-2024)

1/11 (9.09%)

$28.15 (149.34%)

113

Buy

$105

2 months ago
(12-Dec-2024)

0/2 (0%)

$53.23 (102.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 24.86 days on average for the stock forecasts to be realized with a an average price target met ratio 35.82

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on KROS (Keros Therapeutics ) with a proven track record?

SRIKRIPA DEVARAKONDA

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 8 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Andrew Fein with highest potential upside - $36.14

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Julian Harrison with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?